OptimizeRx [NASDAQ:OPRX]: A New Paradigm in Point-of-Care Communication '

OptimizeRx [NASDAQ:OPRX]: A New Paradigm in Point-of-Care Communication

Follow OptimizeRx [NASDAQ:OPRX] on :

William Febbo, CEO & Director, OptimizeRx [NASDAQ:OPRX]William Febbo, CEO & Director, OptimizeRx [NASDAQ:OPRX] While technological innovation has been leaving its footprints on every business turf, healthcare remains one of its most impacted sectors. Over the last few years, technological developments—stemming from innovative diagnostic tools to cutting-edge treatment methods and a myriad of minimally-invasive procedures—have played an instrumental role in shaping the current value-based care realm. Adjacently, today, new advances in health information technology (HIT) are also bringing significant enhancements to patient care, helping people live longer, and offering them an improved quality of life.

Among the numerous breakthroughs that HIT has brought to the fore, the digitalization of patient data collection methods through electronic health records (EHR) is predominant. EHRs have made it easier for doctors and healthcare providers to access accurate patient information on the go, automate numerous administrative tasks, and streamline diagnostic and therapeutic decision-making in real-time.

In fact, many a time, the EHR system surpasses its initial purpose as a prime caregiver interface and emerges as a tool for enriching the pharma-physician relationship. The vast amounts of clinical data and patient information available in EHRs are serving as a crucial data lake for pharma firms to understand their target patients and evaluate how their drugs and medical products perform in the real world. Earlier, in order to acquire this information, pharma companies had to resort to their medical information teams that would directly engage with the physicians. However, in the last few years, due to numerous reasons—which include looming regulatory changes and diminishing physician time—this provider-pharma relationship has been witnessing a steep decline. Fortunately now, pharma companies have an alternate option to bridge this communications gap.

Enter OptimizeRx.

The MI-based digital health company walks into the healthcare space with a completely different approach to tackle the issue. Through its pioneering digital health communication platform, OptimizeRx [NASDAQ:OPRX] helps pharma companies directly collaborate with physicians and their patients at the point of care in order to deliver relevant medication information.

William Febbo, CEO and director of OptimizeRx, says, “We are the only cloud-based point-of-prescribing solution in the market that bridges the communication gap existing between key stakeholders in the care journey: providers, patients, and the pharma companies.”This marks a significant step in the direction toward improving the quality of care.

Also, as the nation’s largest point-of-prescribe promotional platform connecting pharma firms to healthcare providers, OptimizeRx enables more than half of the ambulatory services market to gain access to leading EHR platforms like Allscripts, Amazing Charts, and Quest Diagnostics. This integration ensures a seamless exchange of information between both the parties in real-time to improve out-patient services.

Bridging the Critical Communication Gap

At its core, the OptimizeRx platform helps healthcare providers address communication challenges from three different standpoints: financial support, brand selection, and clinical considerations of specific treatments. When a new treatment option is available, it is important to get the word out to the physicians as soon as possible.

We are the only cloud-based point-of-prescribing solution in the market that bridges the communication gap existing between key stakeholders in the care journey: providers, patients, and the pharma companies

The OptimizeRx platform acts as an ideal communication network for pharma companies to reach the right physicians and quickly spread the word during significant events such as the discovery of a new drug.

Alongside this, physicians can also use the OptimizeRx platform to facilitate patient entry to assistance programs sponsored by pharma, such as co-pay assistance, directly within the EHR. “As out-of-pocket costs increase every year, millions of patients fail to fill their medications or take their prescribed medications,” mentions Febbo. Various industry research sources also point toward high drug costs as a key contributing factor for the increasing rate of non-adherence to medication. As a result, care providers need to empower their patients with innovative ways to make medicines affordable; this is where co-pay assistance programs play a defining role. With the OptimizeRx platform, physicians can view the availability of co-pay assistance programs firsthand, and deliver patient support and relevant brand engagement beyond e-couponing at earlier stages of the patient’s journey to ensure a better treatment experience for the patient, resulting in better medication adherence.

The healthcare staff can easily and conveniently enroll a patient in a co-pay program by either sending a message or transmitting the assistance offer directly to the pharmacy. For example, during a patient visit, physicians can search for a specific drug in OptimizeRx’s EHR vendor network, and, in real-time, receive information on available offers to the particular patient. Then, a coupon or voucher can be printed, texted, or emailed to the patient for them to present it at a retail pharmacy store. By doing this, OptimizeRx not only helps improve medication affordability and encourage adherence but also fosters better clinical outcomes. Simultaneously, OptimizeRx equips healthcare providers with the knowledge of whether a patient has purchased the prescribed drug or picked up their refill. This information helps the physician understand if the patient is continuing with their treatment process and, if not, help them reach out to the patient and suggest necessary support services.

Better Connections. Better Outcomes.

Today, OptimizeRx also plays a crucial role in HIT network optimization. The OptimizeRx platform provides the necessary support services that pharma companies need in order to plan and execute successful point-of-care programs. It all starts with the identification and understanding of the targeted prescribers’ and patients’ needs, followed by an analysis to determine where they connect throughout OptimizeRx’s vast network of EHRs, hospitals, and health systems.

“We leverage the data of this extensive network to help our clients figure out the right way to position their message, optimize it, and ultimately, decide the best approach to deliver the message to patients,” acclaims Febbo.

“OptimizeRx also takes great pride in its distinctive company culture, which is built on the bedrock of encouraging an entrepreneurial approach and always putting clients first”

To that end, OptimizeRx recently established a new partnership with NextGen Healthcare, a CA-based firm that delivers innovative EHR software and practice management systems. The OptimizeRx platform will integrate directly into NextGen’s EHR workflow, helping the extensive network of over 55,000 prescribers gain real-time access to critical information from key pharma manufacturers. As a result of this collaboration, patients will be able to purchase low-cost medications that are vital to their overall well-being.

Experience and Expertise Matter

The unprecedented success of OptimizeRx in the healthcare communication field stems from the company’s team of experienced professionals that are dedicated to delivering innovative solutions. The leadership team brings over 20 years of combined experience in effectively running competent health services and financial businesses. Febbo, who has close to 18 years of experience in the health services and technology landscape, states, “Our success mantra is working with others who know the healthcare and pharmaceutical industries inside out. It is about creating a collaborative approach where we can work together to achieve favorable outcomes.” OptimizeRx also takes great pride in its distinctive company culture, which is built on the bedrock of encouraging an entrepreneurial approach and always putting clients first.

As a part of its plan for the future, the firm is looking to add new EHR partners to its network in order to give pharma companies access to more physicians. OptimizeRx is adjacently working on scaling the patient engagement side of its business through acquisitions of leading digital healthcare management providers. In light of this, the firm recently acquired New York-based RMDY Health, a leading provider of turnkey digital therapeutics solutions built for the health and wellness industries. Febbo believes this merger will enhance and extend the OptimizeRx platform’s capabilities to other patient engagement markets and support its mission of improving medication adherence and care coordination. “This will help us accelerate our plans to move beyond pharmaceutical clients and expand our network to other MedTech and healthcare wellness markets as well as open doors to a new wave of digital health products,” he affirms. And, one such arena, according to Febbo, is the landscape of specialty drugs and complex therapies. As personalized medicine shows promising growth and innovation, and specialty treatments are more commonly prescribed, platforms like OptimizeRx that exist at the point-of-care will become a powerful enabler of communication between the pharma industry and healthcare professionals. “Ultimately, improved communication is a win-win for all,” quips Febbo, as a concluding note—reiterating OptimizeRx’s core belief.

- Alex Dsouza
    December 20, 2019
Share this Article:
OptimizeRx [NASDAQ:OPRX]

OptimizeRx [NASDAQ:OPRX]

Rochester, MI

William Febbo, CEO & Director

Through its pioneering digital health communication platform, MI-based digital health company, OptimizeRx [NASDAQ:OPRX] gives pharma companies critical access to directly collaborate with physicians and their patients in order to deliver the relevant medication information. As the nation’s largest point-of-prescribe communication platform connecting pharma firms to healthcare providers, OptimizeRx technology is available across more than half of the ambulatory services market within leading EHR platforms like Allscripts, Amazing Charts, and Quest Diagnostics. This integration ensures a seamless exchange of real-time information across diverse provider workflow systems to improve out-patient services

OptimizeRx [NASDAQ:OPRX] News

OptimizeRx's Developmental Deal For Integrated Platform

The business’s new platform enables unparalleled transparency into patient medication behavior along with offering access to patient-provider-pharma communication across the care field and in a range of care settings.

FREMONT, CA: In a recent development, OptimizeRx, a premier of digital health solutions for life science enterprises and payers, has sealed an important business deal for 12 months of admission to its platform and key set of solutions.
Read More

OptimizeRx Appoints Greg Wasson, Former President and CEO of Walgreens Boots Alliance, to Its Board of Directors

ROCHESTER, Mich. - OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has appointed Greg Wasson, former president and CEO of Walgreen Boots Alliance, to its board of directors.

“Consumer awareness of digital health services, and especially the need for better affordability and adherence, has never been greater,” said OptimizeRx CEO and director, William Febbo. “Our platform delivers for the life sciences industry unprecedented access to physicians and patients at the point-of-care. Staying connected with the patient as they enter a physical or virtual pharmacy now presents another important area of opportunity to deliver value to our stakeholders. In light of this, Greg’s experience in building Walgreens as a Fortune 50 company with global reach makes him an exceptionally valuable and timely addition to our board as we look to enhance patient connectivity at the point-of-dispense.”

As president and CEO of Walgreens, Wasson led the company to record sales of $76.4 billion in 2014. He created significant shareholder value by completing game-changing mergers and acquisitions, leading complex organizational and structural change, assembling a diverse and high-performance senior leadership team, and establishing Walgreens as an industry leader. Wasson is largely credited for transforming the iconic 114-year-old domestic company into the first global pharmacy-led, health, well-being, and beauty enterprise via the successful merger with European-based Alliance Boots in 2015.

Prior to being appointed president and CEO of the combined companies, Walgreens Boots Alliance, Wasson had risen through the ranks through a number of positions of increasing responsibility and executive leadership, starting as a Walgreens pharmacist technician in 1981.

Commented Wasson: “Having been fortunate to serve the industry for so many years and in a variety of roles, from pharmacist to CEO, I’ve gained a deep understanding of the profession of pharmacy and value it brings to our healthcare system. I believe there is real opportunity to create more affordability and better adherence to medication and treatments utilizing digital tools at point-of-dispense. I look forward to working with Will and his team as we bring the benefits of the OptimizeRx digital health platform to this critical area of care.”

Subsequent to Walgreens, Wasson has been involved in a number of successful businesses. He currently serves as president of Wasson Enterprise, a family office committed to building sustainable, high-growth businesses that do well by doing good.

Wasson also currently serves on the boards of Health Care Service Corporation and Performance Health Systems, and as the executive chairman of Innovation Associates. He was the co-founder and currently serves on the boards of Cooler Screens, Golden Fleece Beverages, and Innventure.

In 2015, Wasson received the Sheldon W. Fantle Lifetime Achievement Award from the National Association of Chain Drug Stores, and the GMA Hall of Achievement Award from the Grocery Manufacturers Association. In 2016, he was honored with the Distinguished Alumni Award and Career Achievement Award from Purdue University, where he earned his Bachelor of Science in Pharmacy in 1981.

OptimizeRx Named to Financial Times The Americas Fastest-Growing Companies List for the Second Consecutive Year

ROCHESTER, Mich. - OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians, and patients, has received the ranking of #277 by the Financial Times (FT) list of The Americas Fastest Growing Companies 2021. This recognition is presented by the FT and Statista Inc., the world-leading statistics portal and industry ranking provider.

The FT Americas Fastest Growing Companies list ranks companies with the strongest compounded annual revenue growth between 2016 and 2019. OptimizeRx grew more than 46% during that period, showing its strongest growth to date in 2020 with full year revenue up 76% year-over-year. Out of the millions of active companies in North and South America, only the top 500 firms are named to the list.

We are thrilled to be part of the FT Americas Fastest Growing Companies ranking, and proud to see our teams efforts and continuous drive to innovate being recognized for the second year in a row by one of the world's most widely read and respected business publications, said William Febbo, CEO of OptimizeRx. Our platform enhancements over the past year included two critical point-of-care solutions: the integration of AI-powered real-world evidence, and the launch of TelaRep„¢ “ a digital solution that gives prescribers a direct line of communication to the right pharma contact when they need it.

We believe both patients and providers deserve access to actionable and accurate information about prescription medications. As such, we will continue working on solutions and partnerships to improve drug affordability, access, and adherence. OptmizeRxs offerings are transformational to physician-patient engagement and define the new modicum of streamlined communications in an increasingly digital-first world. Additionally, we have only just started to touch on the many possible ways of assisting the healthcare industry overcome customer engagement challenges. Looking ahead, we look forward to making operational progress through the remainder of the year and expect to continue seeing record growth, concluded Mr. Febbo.